Tenders are invited for Tab Tenofovir Disoproxil Fumarate
The Medicines Patent Pool (MPP) announced an expansion of its current licensing agreement with Gilead Sciences for generic manufacture of tenofovir alafenamide (TAF), tenofovir disoproxil fumarate
(TDF) and other Gilead medicines.
The two drug combinations tested include Truvada, which consists of emtricitabine and tenofovir disoproxil fumarate
, and Truvada plus maraviroc, which work by blocking the chemokine receptor, CCR5, which is a target entryway of HIV.
Among 4,758 HIV serodiscordant couples in Kenya and Uganda participating in the Partners Pre-exposure Prophylaxis (PrEP) study, the risk of HIV infection was reduced 62% with tenofovir disoproxil fumarate
(Viread) (P = .
Changes in renal function associated with tenofovir disoproxil fumarate
treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
The Public Patent Foundation (New York, NY) said that the United States Patent and Trademark Office has rejected four key HIV/AIDS drug patents held by Gilead Sciences (Foster City, CA) that relate to the drug known generically as tenofovir disoproxil fumarate
(TDF), a key weapon in the battle against\ HIV/AIDS.
On May 1, 2001, Gilead Sciences announced the submittal of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for approval of tenofovir disoproxil fumarate
The agreements cover the manufacture of TMC278 as a single agent medicine and a license to develop an FDC product using TMC278 with 300 mg tenofovir disoproxil fumarate
and 300 mg lamivudine.
On October 26 the FDA approved Viread (tm) -- generic name tenofovir disoproxil fumarate
, or tenofovir DF.
200 mg emtricitabine + tenofovir disoproxil fumarate
World Health Organization guidelines recommend Emtricitabine, as well as Tenofovir Disoproxil Fumarate
(TDF), as preferred components of first- and second-line HIV therapy.
Emtricitabine and tenofovir disoproxil fumarate
are commercialised by Gilead (NASDAQ:GILD) under the trade names Emtriva(R) and Viread(R), respectively, and are commonly prescribed together as a once-daily, fixed-dose tablet, marketed under the trade name Truvada(R) for use as part of combination therapy.